Article: Phase 1 success rates have been around 6-
Post# of 72440
Phase 2,11-15% success rate.
And here's what they say about Phase 3:
Quote:
Phase III, though, has been a whole other ball game, starting out at 49% in the first 2 years of the decade rising to 62% in 2015-2017. And it’s topped out with a record number of new drug approvals in 2018.
So the next time one of those bashers elsewhere who likes to claim statistical analysis "shows" that IPIX doesn't have a great chance of succeeding with clinical trials.... remind them of these statistics, which are real ones and not their made-up claims.
https://endpts.com/phi-may-still-be-a-killing...pharma-rd/